InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.70
(
-0.11%
)
Bitcoin
64,799.88
(
-0.52%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: masterlongevity post# 124094

Wednesday, 09/28/2011 3:42:46 AM

Wednesday, September 28, 2011 3:42:46 AM

Post# of 252255

ElND005 is a bunch of magic beans.

Phase II data of ELND005 in mild to moderate AD were published in Neurology. In the overall population, trial did not meet its primary efficacy endpoints. In the pre-specified mild AD subgroup (MMSE scores 23-26) there were "encouraging trends":

http://www.transitiontherapeutics.com/media/news.php
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up